Treatment of malaria in children, caused by Plasmodium including malaria caused by multiple drug resistant strains of P. Falciparum.
Indicated for treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients of 5 kg body weight and above.
Administered intravenously or intramuscularly and is indicated for the treatment of severe malaria caused by Plasmodium falciparum, in adults and children.
Treatment of P. falciparum malaria for those patients, in whom Choloroquine resistance is suspected.
High efficacy, low toxicity, high safety and short course for treatment of all forms of malaria, particularly for multi-drug resistant falciparum malaria.
For the treatment of malaria in children and adults caused by all forms of plasmodium and for the relief of pain, headache and feverish conditions.
For the treatment of malaria in children and adults, caused by all forms of plasmodium including severe malaria caused by multiple drug resistant strains.
Treatment of malaria. Amodiaquine is active on numerous strains of chloroquine-resistant Plasmodium falciparum.
For Causal prophylaxis of (P. falciparum) malaria; proguanil also suppresses other forms of malaria, and it is used to reduce transmission of infection.
Treatment of malaria in children caused by all forms of Plasmodium including acute uncomplicated malaria caused by drug resistant strains of P. falciparum.